These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 406476)

  • 1. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
    Todt H; Wünsche W; Korth G
    Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of atypical absences with a combination of succinimide and dipropylacetate (author's transl)].
    Schneble H
    Dtsch Med Wochenschr; 1975 Jul; 100(30):1564-7. PubMed ID: 808402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Depakine (sodium dipropylacetate) in the treatment of epilepsies resistant to other drugs (EEG clinical study in 35 cases followed up for 3-12 months)].
    Pazzaglia P; Lugaresi E
    Riv Neurol; 1972; 42(2):185-201. PubMed ID: 4627220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Austrian complex-study on dipropylacetate. Pediatric experiences].
    Groh Ch; Rosenmayr FW
    Padiatr Padol; 1976; 11(1):178-85. PubMed ID: 814526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences].
    Lüdemann G; Cammann R-J ; Knaape H-H
    Psychiatr Neurol Med Psychol (Leipz); 1975 Feb; 27(2):101-7. PubMed ID: 812129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosomal investigations in children with pyknolepsy on dipropylacetate monotherapy.
    Kotlarek F; Faust J
    Hum Genet; 1978 Sep; 43(3):329-31. PubMed ID: 100408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic results with sodium dipropylacetate in infantile myoclonus epilepsy].
    Papini M; Martinetti MG; Guerri S; Pasquinelli A
    Riv Neurol; 1976; 46(6):503-7. PubMed ID: 827804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems posed by the therapeutic combination of phenobarbital and sodium dipropylacetate. Apropos of a case].
    Millet Y; Sainty JM; Galland MC; Sidoine R; Jouglard J
    Eur J Toxicol Environ Hyg; 1976; 9(6):381-3. PubMed ID: 799967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs for petit mal].
    Aicardi J
    Therapie; 1975; 30(2):161-73. PubMed ID: 808874
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of diphenylhydantoin and primidone serum concentration by addition of dipropylacetate, a new anticonvulsant drug.
    Windorfer A; Sauer W; Gädeke R
    Acta Paediatr Scand; 1975 Sep; 64(5):771-2. PubMed ID: 1101639
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of ethosuximide and valproate in the treatment of epilepsy.
    Wallace SJ
    Neurol Clin; 1986 Aug; 4(3):601-16. PubMed ID: 3092003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Childhood absence epilepsy(pyknolepsy)].
    Ono T
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):65-8. PubMed ID: 12483830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)].
    Hosokawa K; Kugoh T; Otsuki S
    No To Shinkei; 1977 Aug; 29(8):885-90. PubMed ID: 409421
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note].
    Piccinin GL; Morocutti C; Urciuoli R; Bernardi G
    Clin Ter; 1977 Jul; 82(1):25-30. PubMed ID: 332440
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of ergenyl (dipropylacetate) in hypsarrhythmia].
    Rohmann E; Arndt R
    Kinderarztl Prax; 1976 Mar; 44(3):109-13. PubMed ID: 775170
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Preliminary experience with sodium valproate.
    Ronthal M
    S Afr Med J; 1975 Jun; 49(27):1077. PubMed ID: 1098174
    [No Abstract]   [Full Text] [Related]  

  • 20. Approach to a combined pharmacologic therapy of childhood hyperkinesis.
    Knobel M
    Behav Neuropsychiatry; 1974 Apr-1975 Mar; 6(1-12):87-90. PubMed ID: 4619768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.